⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for IRCI Gynae Sarcomas, High Grade Uterine Sarcoma

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: IRCI Gynae Sarcomas, High Grade Uterine Sarcoma

Official Title: A Randomized Double-blind Phase II Study Evaluating the Role of Maintenance Therapy With Cabozantinib in High Grade Uterine Sarcoma (HGUtS) After Stabilization or Response to Doxorubicin +/- Ifosfamide Following Surgery or in Metastatic First Line Treatment

Study ID: NCT01979393

Conditions

Uterine Sarcoma

Interventions

Cabozantinib
Placebo

Study Description

Brief Summary: This study aims to investigate a drug called Cabozantinib which belongs to a family of drugs that have effects on tumour growth, blood supply, invasion and spread. Therefore, we want to find out whether taking cabozantinib after treatment with surgery and chemotherapy is effective and safe for patients who responded or had stable disease after their chemotherapy. All participants will receive 4-6 cycles of standard chemotherapy. Those with stabilization or response to the standard chemotherapy will be split into 2 groups (cabozantinib or placebo).

Detailed Description:

Eligibility

Minimum Age: 18 Years

Eligible Ages: ADULT, OLDER_ADULT

Sex: FEMALE

Healthy Volunteers: No

Locations

Institut Bergonie, Bordeaux, , France

Institut Bergonie, Bordeaux, , France

Centre Leon Berard, Lyon, , France

Institut de Cancerologie de l'Ouest (ICO) - Centre Rene Gauducheau, Nantes, , France

Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, , Italy

Academisch Medisch Centrum at University of Amsterdam, Amsterdam, , Netherlands

Hospital General Vall D'Hebron, Barcelona, , Spain

Hospital Universitario San Carlos, Madrid, , Spain

Cambridge University Hospital NHS - Addenbrookes Hospital, Cambridge, , United Kingdom

NHS Greater Glasgow and Clyde - Beatson West of Scotland Cancer Centre - Gartnavel General Hospital, Glasgow, , United Kingdom

Leeds Teaching Hospitals NHS Trust - St. James's University Hospital, Leeds, , United Kingdom

Royal Marsden Hospital, London, , United Kingdom

University College London Hospitals NHS Foundation Trust - University College Hospital, London, , United Kingdom

Nottingham University Hospitals NHS Trust - City Hospital, Nottingham, , United Kingdom

Oxford University Hospitals NHS Trust - Churchill Hospital, Oxford, , United Kingdom

Contact Details

Name: Isabelle Ray-Coquard, MD

Affiliation: Centre Léon Bérard, Lyon, France

Role: STUDY_CHAIR

Name: Nicholas Reed, MD

Affiliation: NHS Greater Glasgow and Clyde - Beatson West of Scotland Cancer Centre - Gartnavel General Hospital , Glasgow, United Kingdom

Role: PRINCIPAL_INVESTIGATOR

Useful links and downloads for this trial

Clinicaltrials.gov

Google Search Results

Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: